Investigation of Connexin43 and E-cadherin Expression in Hepatocellular Carcinoma by Immunohistochemistry

AN Junling,XU Zhengshun,ZHANG Tianyi,Zhang Zhaohui
DOI: https://doi.org/10.3969/j.issn.1002-3070.2005.04.006
2005-01-01
Abstract:Objective To investigate the expression of connexin43 and E-cadherin in hepatocellular carcinoma and their relationship with clinicopathologic parameter. Methods The expression of connexin43 and E-cadherin were studied in 47 cases of hepatocellular carcinoma by using streptavidin peroxidase immunohistochemistry. Results The positive rate of Cx43 and E-cadherin in the HCC was 42.55 % and 46.81 %, respectively. With the progression of hepatocellular carcinoma course, the positive rate of Cx43 was decreased (P= 0.006 ). Cx43 positive rate was lower in the group with cirrhosis background than that in the group without cirrhosis background (χ2= 4.7135 , P= 0.03 ). In comparision with the group of intrahepatic vascular embolism, E-cadherin positive rate was apparently decreased in the group without intrahepatic vascular embolism (P= 0.028 ). No significant association were found between the expression of Cx43, E-cadherin and tumor size, the extent of differentiation. Spearman correlation analysis revealed that the expression of Cx43 and E-cadherin had no significant relationship. Conclusion The aberrant expression of Cx43 and E-cadherin may play a role in occurrence, progression of hepatocellular carcinoma. Detecting the expression of Cx43 and E-cadherin may be contribute to synthetically evaluating the biological behavior of hepatocellular carcinoma.
What problem does this paper attempt to address?